Cardiol Therapeutics Inc Class A
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -7,650 | -8,404 | -9,940 | -13,939 |
EBIT | -7,676 | -8,429 | -9,989 | -14,140 |
Net Income | -8,354 | -8,287 | -8,178 | -12,728 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -4,557 | -7,165 | -5,599 | -7,776 |
Cash | 18,195 | 23,292 | 30,580 | 15,885 |
Basic Shares | 82,653 | 82,608 | 69,841 | 69,841 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $78 |
Gross Profit | -248 | -219 | 78 | |
EBITDA | -40,114 | -29,590 | -41,156 | -38,444 |
EBIT | -40,276 | -29,785 | -41,375 | -38,664 |
Net Income | -36,677 | -28,128 | -30,930 | -31,638 |
Net Change In Cash | 0 | 0 | 0 | 78 |
Free Cash Flow | -25,082 | -25 | -27,295 | -23,563 |
Cash | 30,580 | 34,931 | 59,469 | 83,899 |
Basic Shares | 71,567 | 64,463 | 62,505 | 43,222 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.07 |
2025-03-31 | -$0.10 |
2024-12-31 | -$0.09 |
